The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and …
W Wu, Y Cheng, H Zhou, C Sun, S Zhang - Virology journal, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) continues to take a heavy toll on personal
health, healthcare systems, and economies around the globe. Scientists are expending …
health, healthcare systems, and economies around the globe. Scientists are expending …
COVID-19 pandemic and vaccines update on challenges and resolutions
The coronavirus disease (COVID-19) is caused by a positive-stranded RNA virus called
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), belonging to the …
Sandwich mode lateral flow assay for point-of-care detecting SARS-CoV-2
F Pei, S Feng, W Hu, B Liu, X Mu, Q Hao, Y Cao, W Lei… - Talanta, 2023 - Elsevier
The global corona virus disease 2019 (COVID-19) has been announced a pandemic
outbreak, and has threatened human life and health seriously. Severe acute respiratory …
outbreak, and has threatened human life and health seriously. Severe acute respiratory …
Discriminative electrochemical biosensing of wildtype and omicron variant of SARS-CoV-2 nucleocapsid protein with single platform
L Liv, A Baş - Analytical Biochemistry, 2022 - Elsevier
Electrochemical biosensors for determining wildtype and omicron variant of the severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) nucleocapsid antigen in …
respiratory syndrome-coronavirus-2 (SARS-CoV-2) nucleocapsid antigen in …
Development and characterisation of cysteine-based gold electrodes for the electrochemical biosensing of the SARS-CoV-2 spike antigen
This article describes three novel electrochemical biosensing platforms developed to
determine the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) spike …
determine the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) spike …
Fujirebio Lumipulse SARS-CoV-2 antigen immunoassay: pooled analysis of diagnostic accuracy
We provide here a pooled analysis of accuracy of Fujirebio Lumipulse SARS-CoV-2 Antigen
chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infections. An electronic …
chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infections. An electronic …
CdTe QDs-sensitized TiO2 nanocomposite for magnetic-assisted photoelectrochemical immunoassay of SARS-CoV-2 nucleocapsid protein
A sensitive, reliable, and cost-effective detection for SARS-CoV-2 was urgently needed due
to the rapid spread of COVID-19. Here, a “signal-on” magnetic-assisted PEC immunosensor …
to the rapid spread of COVID-19. Here, a “signal-on” magnetic-assisted PEC immunosensor …
Enzyme linked oligonucleotide assay for the sensitive detection of SARS-CoV-2 variants
M Shola David, D Kanayeva - Frontiers in Cellular and Infection …, 2022 - frontiersin.org
The exponential spread of COVID-19 has prompted the need to develop a simple and
sensitive diagnostic tool. Aptamer-based detection assays like ELONA are promising since …
sensitive diagnostic tool. Aptamer-based detection assays like ELONA are promising since …
Improved Stability and Manufacturability of Nucleocapsid Antigens for SARS-CoV2 Diagnostics through Protein Engineering
The COVID-19 pandemic has had a significant impact on human health management. A
rapid diagnosis of SARS-CoV2 at the point-of-care (POC) is critical to prevent disease …
rapid diagnosis of SARS-CoV2 at the point-of-care (POC) is critical to prevent disease …
Patent intelligence of RNA viruses: Implications for combating emerging and re-emerging RNA virus based infectious diseases
P Devarapalli, P Kumari, S Soni, V Mishra… - International Journal of …, 2022 - Elsevier
The recent outbreak of one of the RNA viruses (2019-nCoV) has affected most of the
population and the fatalities reported may label it as a modern-day scourge. Active research …
population and the fatalities reported may label it as a modern-day scourge. Active research …